Panel conference. Antithrombotic therapy of artificial organs

Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids.

Thrombosis and haemostasis·2001

Thrombogenesis in sickle cell disease.

The Journal of laboratory and clinical medicine·2001

The sensitivity of indicators of thrombosis initiation to a bileaflet prosthesis leakage stimulus.

The Journal of heart valve disease·2001

Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers.

Blood·2001

Effects of Mpl ligands on platelet production and function in nonhuman primates.

Stem cells (Dayton, Ohio)·2000

Pulmonary artery catheterization and clinical outcomes: National Heart, Lung, and Blood Institute and Food and Drug Administration Workshop Report. Consensus Statement.

JAMA·2000

Mechanisms of hypersensitivity reactions during hemodialysis.

Transactions - American Society for Artificial Internal Organs·1985

Is the dialysate fluid source of complement activating factors?

Transactions - American Society for Artificial Internal Organs·1985

Development and initial clinical application of the HKL Thrombus Burden Classification for endovascular salvage of thrombosed haemodialysis access.

The journal of vascular access·2026

Clonal hematopoiesis in immune-related and neurological disorders.

Immunological medicine·2026

Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial).

British journal of haematology·2026

Recurrent Postpartum Atypical Hemolytic Uremic Syndrome Caused by a C3 Pathogenic Variant: A Case Report.

International journal of women's health·2026

Point-of-care assessment of complement activation in the ICU: a feasibility study of rapid terminal complement complex detection in critical illness.

Frontiers in immunology·2026

Utility of TcPO2 in Assessing Microcirculatory Improvement and Minimizing Amputation Levels for Hemodialysis Access-Induced Distal Ischemia: A Case Report.

Yonago acta medica·2026

Related Experiment Videos

Panel conference. Antithrombotic therapy of artificial organs

Related Concept Videos

Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids.

Thrombogenesis in sickle cell disease.

The sensitivity of indicators of thrombosis initiation to a bileaflet prosthesis leakage stimulus.

Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers.

Effects of Mpl ligands on platelet production and function in nonhuman primates.

Pulmonary artery catheterization and clinical outcomes: National Heart, Lung, and Blood Institute and Food and Drug Administration Workshop Report. Consensus Statement.

Mechanisms of hypersensitivity reactions during hemodialysis.

Is the dialysate fluid source of complement activating factors?

Development and initial clinical application of the HKL Thrombus Burden Classification for endovascular salvage of thrombosed haemodialysis access.

Clonal hematopoiesis in immune-related and neurological disorders.

Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial).

Recurrent Postpartum Atypical Hemolytic Uremic Syndrome Caused by a C3 Pathogenic Variant: A Case Report.

Point-of-care assessment of complement activation in the ICU: a feasibility study of rapid terminal complement complex detection in critical illness.

Utility of TcPO2 in Assessing Microcirculatory Improvement and Minimizing Amputation Levels for Hemodialysis Access-Induced Distal Ischemia: A Case Report.

Related Experiment Videos

Panel conference. Antithrombotic therapy of artificial organs

Related Concept Videos

Related Articles